IL6 and alopecia: After treatment, levels of TNF-α, IL-10, IL-8, and IL-6 in patients of the ASLC group were lower than those of the SLC group (p≤0.05) Fig.2 No significant difference was found in the incidences of alopecia, liver damage, nausea and vomiting, and leukopenia between the groups (p>0.05) Table-III.